Douglas Pharma Of New Zealand To Expand Globally With New Partner
This article was originally published in PharmAsia News
Executive Summary
Douglas Pharmaceuticals of New Zealand is considering a partnership with an international drug maker to expand its expertise in immuno-suppression drugs.
Douglas Pharmaceuticals of New Zealand is considering a partnership with an international drug maker to expand its expertise in immuno-suppression drugs. Sir Graeme Douglas, the firm’s founder and managing director, said it was working with an unidentified international partner to expand its foreign sales beyond the 35 nations it now exports to, producing $85 million in sales. The partner is to provide entrée to areas in Africa, Central America, Eastern Europe and South America, according to Douglas. (Click here for more
)
“Douglas Pharmaceuticals Expands Exports” – Fairfax News (New Zealand) (1/18/12)